PRISM’s Response: TGA Rescheduling of Psilocybin and MDMA Independent Expert Review Panel Report
Media Release: 16th December 2021 TGA Rescheduling of Psilocybin and MDMA: Delegate’s Final Decision On December 15th, the Therapeutic Goods Administration (TGA) announced the [...]